These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1869296)

  • 1. Thermic response of selective muscarinic agonists and antagonists in rat.
    Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1991 Feb; 29(2):131-5. PubMed ID: 1869296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of selective muscarinic receptor agonists and antagonists on active-avoidance learning acquisition in rats.
    Sen AP; Bhattacharya SK
    Indian J Exp Biol; 1991 Feb; 29(2):136-9. PubMed ID: 1869297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of muscarinic receptor agonists and antagonists on response of non-extensor rats to maximal electroshock.
    Bhattacharya SK; Sen AP; Mitra SK
    Indian J Exp Biol; 1991 Mar; 29(3):237-40. PubMed ID: 1874538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptor-mediated phosphoinositide hydrolysis in the rat retina.
    Moroi-Fetters SE; Neff NH; Hadjiconstantinou M
    J Pharmacol Exp Ther; 1988 Aug; 246(2):553-7. PubMed ID: 2841451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of muscarinic receptor agonists and antagonists on swim-stress-induced 'behavioural despair' in rats.
    Bhattacharya SK; Sen AP
    J Psychopharmacol; 1991 Jan; 5(1):77-81. PubMed ID: 22282123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central muscarinic receptor subtypes and carrageenin-induced paw oedema in rats.
    Bhattacharya SK; Sen AP; Das Gupta G; Seth K; Seth PK
    Res Exp Med (Berl); 1991; 191(1):65-76. PubMed ID: 1674619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
    James MK; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Jan; 240(1):203-15. PubMed ID: 3806384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease.
    Fisher A; Brandeis R; Karton I; Pittel Z; Gurwitz D; Haring R; Sapir M; Levy A; Heldman E
    J Pharmacol Exp Ther; 1991 Apr; 257(1):392-403. PubMed ID: 2019998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T; Boselli C
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central muscarinic cholinergic influences on ethanol sensitivity in long-sleep and short-sleep mice.
    Erwin VG; Korte A; Jones BC
    J Pharmacol Exp Ther; 1988 Dec; 247(3):857-62. PubMed ID: 3204520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex.
    Forray C; el-Fakahany EE
    Mol Pharmacol; 1990 Jun; 37(6):893-902. PubMed ID: 2163015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
    Flynn DD; Mash DC
    J Pharmacol Exp Ther; 1989 Aug; 250(2):573-81. PubMed ID: 2760841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of muscarinic receptor agonists and antagonists on rat brain serotonergic activity.
    Bhattacharya SK; Sen AP
    J Neural Transm Gen Sect; 1992; 90(3):241-7. PubMed ID: 1283683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of muscarinic receptors in lamb isolated coronary resistance arteries.
    Simonsen U; Prieto D; Rivera L; Hernández M; Mulvany MJ; García-Sacristán A
    Br J Pharmacol; 1993 Aug; 109(4):998-1007. PubMed ID: 8401954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin-releasing hormone in membranes of rat frontal cortex.
    Onali P; Olianas MC
    J Pharmacol Exp Ther; 1998 Aug; 286(2):753-9. PubMed ID: 9694930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists.
    Ringdahl B; Roch M; Jenden DJ
    J Pharmacol Exp Ther; 1987 Aug; 242(2):464-71. PubMed ID: 3612545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP; Heath I; Hendrix JC; Shannon HE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptor agonist-mediated modulation of neuronal activity in rat cerebral cortex.
    Lin Y; Phillis JW
    Eur J Pharmacol; 1991 Jul; 200(1):45-52. PubMed ID: 1722754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.